Michael Reutlinger
16Patents
3h-index
34Co-inventors
49Inventor score
Filing activity: Aug 22, 2017 → Mar 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9980929B2 | Trifluoromethylpropanamide derivatives | Chemistry; Metallurgy | 5 | Active |
| US10428108B2 | Difluoroketamide derivatives | Human Necessities | 5 | Active |
| US10941147B2 | Bicyclic heteroaryl derivatives | Human Necessities | 4 | Active |
| US10730881B2 | Fused pyrimidine derivatives | Chemistry; Metallurgy | 2 | Active |
| US11739095B2 | Substituted benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepines as GABA A GAMMA1 positive allosteric modulators | Human Necessities | 2 | Active |
| US10899766B2 | Bridged piperidine derivatives | Chemistry; Metallurgy | 1 | Active |
| US11319314B2 | Phenoxytriazoles | Chemistry; Metallurgy | 1 | Active |
| US10647721B2 | Bicyclic heteroaryl derivatives | Human Necessities | 0 | Active |
| US10870623B2 | Trifluoromethylpropanamide derivatives as HTRA1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11059858B2 | Difluoroketamide derivatives as HtrA1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11014963B2 | Trifluoromethylpropanamide derivatives as HTRA1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11440915B2 | Triazolo-azepine derivatives | Human Necessities | 0 | Active |
| US11414420B2 | Pyrimidine derivatives | Chemistry; Metallurgy | 0 | Active |
| US11001555B2 | Difluoroketamide derivatives as HTRA1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10669276B2 | Fused pyrimidine derivatives | Chemistry; Metallurgy | 0 | Active |
| US10865182B2 | Difluoroketamide derivatives as HtrA1 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.